ストックスクリーナーアプリを入手
0.7717
0.30%
-0.0023
アフターアワーズ：
.77
-0.0017
-0.22%
前日終値:
$0.774
開ける：
$0.77
24時間の取引高:
3.85M
Relative Volume:
3.36
時価総額：
$73.97M
収益：
$34.48M
当期純損益:
$-102.07M
株価収益率:
-0.5286
EPS:
-1.46
ネットキャッシュフロー:
$-104.90M
1週間 パフォーマンス:
-2.97%
1か月 パフォーマンス:
-17.83%
6か月 パフォーマンス:
-58.95%
1年 パフォーマンス:
-79.20%
1日の値動き範囲:
$0.7301
$0.7982
1週間の範囲:
$0.7301
$0.899
52週間の値動き範囲:
$0.66
$3.93
Caribou Biosciences Inc Stock (CRBU) Company Profile
名前
Caribou Biosciences Inc
セクター
電話
510-982-6030
住所
2929 7TH STREET, SUITE 105, BERKELEY
CRBU を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
0.7717 | 73.97M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.49 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.86 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
620.97 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
254.85 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.46 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-11-08 | 開始されました | Cantor Fitzgerald | Neutral |
| 2023-10-31 | 開始されました | Evercore ISI | Outperform |
| 2023-07-11 | 開始されました | Truist | Buy |
| 2022-02-18 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-30 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-15 | アップグレード | Citigroup | Neutral → Buy |
| 2021-08-17 | 開始されました | BofA Securities | Buy |
| 2021-08-17 | 開始されました | Citigroup | Neutral |
| 2021-08-17 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Caribou Biosciences Inc (CRBU) 最新ニュース
H.C. Wainwright cuts Caribou Biosciences stock target to $3 - Investing.com
Quarterly Snapshot: Quick and Current Ratios for Caribou Biosciences Inc (CRBU) - DWinneX
Caribou Biosciences Inc (CRBU) Stock: A Year of Decreases and Increases - investchronicle.com
Caribou Biosciences Inc (CRBU) receives an In-line rating from Evercore ISI - knoxdaily.com
Russell Investments Group Ltd. Boosts Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Caribou Biosciences (CRBU) Restructures, Focuses on Key Oncology Programs - GuruFocus
Caribou stock in focus after portfolio shakeup (CRBU:NASDAQ) - Seeking Alpha
Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs - marketscreener.com
Caribou Biosciences (CRBU) Shifts Focus to Oncology, Reduces Wor - GuruFocus
Caribou Biosciences Inc [CRBU] Shares Fall Approximately -78.12% Over the Year - knoxdaily.com
Caribou Biosciences extends cash runway, focuses on oncology - Investing.com
Caribou Biosciences, Inc. Announces Strategic Pipeline Prioritization and Workforce Reductions to Extend Cash Runway into H2 2027 - Nasdaq
Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 ... - Enidnews.com
East Bay biotech to cut a third of its workforce, reset around two cancer programs - The Business Journals
Caribou Biosciences Inc (CRBU) stock analysis: A simple moving average approach - uspostnews.com
CRBU’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Recent Insider Activity Suggests Potential Gains for Caribou Biosciences Inc (CRBU) - knoxdaily.com
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by JPMorgan Chase & Co. - Defense World
Caribou Biosciences, Inc. (NASDAQ:CRBU) Stake Boosted by JPMorgan Chase & Co. - American Banking and Market News
Brokerages Set Caribou Biosciences, Inc. (NASDAQ:CRBU) PT at $10.33 - Defense World
Q1 Earnings Estimate for CRBU Issued By Leerink Partnrs - Defense World
THE ROSEN LAW FIRM, P. A., Caribou Biosciences, Inc. - The Bradford Era
Investigation announced for Long-Term Investors in shares - openPR.com
American Century Companies Inc. Grows Stake in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Sei Investments Co. Buys New Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Prudential Financial Inc. Sells 111,100 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect - markets.businessinsider.com
Caribou Biosciences Inc [CRBU] President and CEO makes an insider purchase of 20,000 shares worth 20400.0. - knoxdaily.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Thrivent Financial for Lutherans Acquires 79,636 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences stock hits 52-week low at $0.71 - Investing.com India
Caribou Biosciences stock hits 52-week low at $0.71 By Investing.com - Investing.com South Africa
Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Investors to Connect - markets.businessinsider.com
Bank of New York Mellon Corp Has $358,000 Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com
Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives $10.33 Consensus Target Price from Analysts - Defense World
Caribou Biosciences stock hits 52-week low at $0.95 By Investing.com - Investing.com Canada
Caribou Biosciences stock hits 52-week low at $0.95 - Investing.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Investors to Learn More About the Investigation - Markets Insider
Caribou Biosciences’ (CRBU) “Buy” Rating Reiterated at HC Wainwright - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Reach Out - Markets Insider
Caribou Biosciences’ SWOT analysis: CRISPR pioneer’s stock faces critical juncture - Investing.com Canada
Truist Removes Price Target on Caribou Biosciences, Keeps Buy Rating; Price Target Was $19 - Marketscreener.com
US Bancorp DE Buys 26,467 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Connect - Markets Insider
Caribou Biosciences CEO Rachel E. Haurwitz buys $20,400 in stock By Investing.com - Investing.com Australia
Caribou Biosciences CEO Rachel E. Haurwitz buys $20,400 in stock - Investing.com India
Caribou Biosciences Inc (CRBU) 財務データ
収益
当期純利益
現金流量
EPS
0.19%
大文字化:
|
ボリューム (24 時間):